Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Eimeren TV et al. – The authors propose that DAs prevent pauses in dopamine transmission and thereby impair the negative reinforcing effect of losing. The findings raise the question of whether pathological gambling may in part stem from an impaired capacity of the OFC to guide behavior when facing negative consequences.

Related Articles

Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease
Cochrane Reviews, 10/09/09    Relevance Score: 93%

Increased Dopamine Is Associated With the cGMP and Homocysteine Pathway in Female Migraineurs
Headache: The Journal of Head and Face Pain, 10/07/09    Relevance Score: 90%

Altered Effect of Dopamine Transporter 3UTR VNTR Genotype on Prefrontal and Striatal Function in Schizophrenia
Archives of General Psychiatry, 11/06/09    Relevance Score: 87%

Glycine Receptors Involved in Acamprosates Modulation of Accumbal Dopamine Levels: An In Vivo Microdialysis Study
Alcoholism, 10/29/09    Relevance Score: 87%

Urinary Dopamine Excretion and Renal Responses to Fenoldopam Infusion in Blacks and Whites
The Journal of Clinical Hypertension, 10/12/09    Relevance Score: 87%

Today in Neuro/Psych pharmacology...keeping you current

Lundbeck initiates clinical phase II trials with Lu AE58054 as augmentation treatment in Alzheimer's disease
Lundbeck, 11/29/09

Use of Antidepressants in the Treatment of Chronic Pain
Annals, Academy of Medicine, Singapore, 11/29/09

Mitoxantrone treatment in multiple sclerosis induces TH2-type cytokines
Acta Neurologica Scandinavica, 11/27/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address